| Feb 6, 2014
| 3:45 PM
WASHINGTON – The United States could be losing its edge in science and technology as emerging nations rapidly increase their investment in research and development, according to new indicators released Thursday by the National Science Board....
| Apr 8, 2014
| 10:58 AM
One of the industrial-looking buildings at Panduit's compound at 175th Street and Ridgeland Avenue in Tinley Park will be sporting a more modern look this year, if all goes according to plan.
But the fate of the rest of the 65-acre property remains...
| Apr 9, 2014
| 7:46 AM
Lupin Pharmaceuticals, Inc. has placed its name in lights over the Inner Harbor, a mark of the Indian drug manufacturer's growing presence since the company located its U.S. headquarters in Baltimore more than a decade ago.
Lupin, which today sells...
| Jan 13, 2014
| 8:45 PM
WASHINGTON – Key elements of a new nuclear agreement between Iran and six world powers are contained in an informal, 30-page text not yet publicly acknowledged by Western officials, Iran’s chief negotiator said Monday.
| Jan 27, 2014
| 1:05 PM
WASHINGTON – The interim nuclear deal between Iran and world powers will allow Tehran to continue far more research and development on centrifuges to enrich uranium than has been publicly recognized, according to a veteran Washington nuclear...
| Mar 12, 2014
Re "Prices of new drugs tough to take," March 10
I understand the necessity for drug companies to recoup research and development costs. But in regard to a medication that can cure hepatitis C, a spokesman for the maker of one drug that costs about $1,...
| Oct 1, 2013
| 8:33 AM
Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.
That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
| Nov 23, 2013
| 7:24 PM
WASHINGTON — Despite intense pressure to hold down federal spending, the Defense Department is launching a high-priced effort to create its own production pipeline for vaccines and biodefense drugs — an initiative that defies the advice of...
| Dec 18, 2013
| 11:55 AM
Followers of Herbalife, the Los Angeles peddler of nutritional supplements, know it's actually two stories rolled into one.
One is the story of how a company with a questionable business model, overhyped products, and an almost invisible research and...
| Dec 19, 2013
| 2:31 PM
There's a new chef at the Bazaar by José Andrés, the new-fashioned tapas restaurant in the SLS Hotel at Beverly Hills. Holly Jivin succeeds Joshua Whigham as chef de cuisine. Whigham is returning to Washington, D.C., as a research and development chef...
| Jul 15, 2013
| 5:20 PM
Announcing Monday what officials are describing as a culture shift, NASCAR plans to make significant changes to its competition department over the next several years with a goal of making information and rules enforcement more transparent for teams and...